Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review

Clinical and Experimental Ophthalmology - Tập 44 Số 4 - Trang 260-277 - 2016
Daniel Shu Wei Ting1,2, Chui Ming Gemmy Cheung3,1,2, Tien Yin Wong3,1,2
1Singapore Eye Research Institute, Singapore, Singapore
2Singapore National Eye Center, Singapore Health Service (SingHealth), Singapore, Singapore
3Duke-NUS Graduate Medical School, Singapore, Singapore

Tóm tắt

AbstractDiabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly people globally. Early detection and prompt treatment allow prevention of diabetes‐related visual impairment. Patients with diabetes require regular follow‐up with primary care physicians to optimize their glycaemic, blood pressure and lipid control to prevent development and progression of DR and other diabetes‐related complications. Other risk factors of DR include higher body mass index, puberty and pregnancy, and cataract surgery. There are weaker associations with some genetic and inflammatory markers. With the rising incidence and prevalence of diabetes and DR, public health systems in both developing and developed countries will be faced with increasing costs of implementation and maintenance of a DR screening program for people with diabetes. To reduce the impact of DR‐related visual loss, it is important that all stakeholders continue to look for innovative ways of managing and preventing diabetes, and optimize cost‐effective screening programs within the community.

Từ khóa


Tài liệu tham khảo

10.1016/S0161-6420(98)96025-0

10.2337/diacare.27.5.1047

10.1080/09286580701396720

10.1016/S0140-6736(09)62124-3

International Diabetes Federation. Diabetes atlas 6th ed Brussels Belgium. 2015.

10.1001/jama.1993.03500100088034

10.1016/S0161-6420(13)38012-9

10.1136/bmj.320.7250.1627

Resnikoff S, 2004, Global data on visual impairment in the year 2002, Bulletin of the World Health Organization, 82, 844

10.2337/dc11-1909

10.1016/j.survophthal.2012.01.004

10.1007/BF00398055

10.1001/archopht.122.4.546

10.1016/S0168-8227(99)00134-5

10.1016/S1056-8727(99)00063-X

10.1111/j.1464-5491.1995.tb00407.x

10.5694/j.1326-5377.1994.tb125943.x

Scott A, 2004, Diabetes in children and young adults in Waikato Province, New Zealand: outcomes of care, N Z Med J, 117, U1219

10.2337/diacare.28.3.509

10.1016/S0161-6420(95)31052-4

10.1016/S0140-6736(03)12267-2

10.1007/s001250051594

Giuffre G, 2004, Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle, Ophthalmologie, 242, 535

10.1111/j.1600-0420.2004.00270.x

10.1136/bjo.2006.093393

Hamman RF, 1989, Prevalence and risk factors of diabetic retinopathy in non‐Hispanic whites and Hispanics with NIDDM, San Luis Valley Diabetes Study. Diabetes, 38, 1231

10.1016/j.ophtha.2004.02.002

10.1016/j.ajo.2005.08.063

10.2337/diacare.28.8.1954

10.1016/j.ophtha.2004.02.001

10.2337/diacare.26.6.1731

Mitchell P, 1998, Prevalence of diabetic retinopathy in an older community, The Blue Mountains Eye Study. Ophthalmology, 105, 406

10.1136/bjo.84.8.865

10.1620/tjem.141.Suppl_379

10.1111/j.1442-9071.1985.tb00397.x

He S, 1997, Epidemiologic study of diabetic retinopathy in Capital Steel Company]. [Zhonghua yan ke za zhi, Chinese journal of ophthalmology, 33, 381

10.1016/j.ophtha.2008.09.010

10.1016/j.ophtha.2008.10.003

10.1007/s00417-008-0884-6

10.1136/bmjdrc-2013-000005

10.1167/iovs.11-7698

10.1016/j.ophtha.2012.04.027

10.1007/BF02427275

10.1016/j.ophtha.2008.08.023

10.1016/j.ophtha.2008.10.016

10.2337/dc11-0943

10.1016/S0161-6420(03)00086-1

10.1038/sj.eye.6702771

10.1111/j.1444-0938.2011.00628.x

10.2337/dc09-0615

10.1056/NEJM199309303291401

10.1016/S0161-6420(95)30973-6

10.1056/NEJM200002103420603

10.1016/S0140-6736(98)07019-6

10.1001/jama.298.8.902

10.1056/NEJMoa0806470

Drzewoski J, 2009, The role of “metabolic memory” in the natural history of diabetes mellitus, Pol Arch Med Wewn, 119, 493

10.1001/archopht.116.7.874

10.1016/0140-6736(93)90816-Y

10.1056/NEJMoa1001288

10.1007/s00125-011-2404-1

10.1016/S0161-6420(89)32699-6

10.1016/S0140-6736(07)60198-6

Klein R, 1989, Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?, Archives of internal medicine, 149, 2427, 10.1001/archinte.1989.00390110033008

10.1016/S0140-6736(08)61413-0

10.1016/S0140-6736(08)61412-9

10.1056/NEJMoa0808400

10.1016/S0140-6736(08)61411-7

10.3317/jraas.2002.048

10.1016/S0140-6736(97)06209-0

10.1016/S0272-6386(12)70236-6

10.1016/j.ophtha.2008.05.014

10.1016/j.ophtha.2009.09.005

10.1111/j.1464-5491.2006.01890.x

10.1167/iovs.02-0648

10.1016/S0140-6736(07)61607-9

10.1001/archopht.1984.01040030398010

10.1001/archinte.1997.00440270094008

10.1167/iovs.09-4939

10.2337/diacare.26.2.349

10.2337/diacare.24.2.284

10.2337/diacare.28.6.1383

10.2337/diacare.27.2.530

10.1111/j.1464-5491.2010.02958.x

10.1007/s00125-010-1697-9

10.2337/diacare.13.10.1034

10.2337/diacare.26.4.1224

10.1016/S1056-8727(03)00073-4

10.2337/diacare.23.8.1084

10.2337/diacare.13.1.34

10.1016/j.jfo.2010.06.005

10.1016/0039-6257(88)90172-5

10.1001/archopht.117.12.1600

10.1097/ICU.0b013e328333e9c1

10.1136/bjo.80.9.789

10.2337/dc11-0672

10.1517/14712598.2012.641531

10.1111/j.1464-5491.2007.02217.x

10.1007/s00125-005-1799-y

10.1167/iovs.04-1057

10.1007/s10238-009-0084-7

10.1007/s10238-008-0173-z

10.1016/j.jdiacomp.2007.03.001

10.1001/jamaophthalmol.2013.2299

10.1001/jamaophthalmol.2013.5024

Leslie RD, 1982, Diabetic retinopathy in identical twins, Diabetes, 31, 19, 10.2337/diab.31.1.19

Clustering of long‐term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997; 46(11): 1829–39.

10.2337/db07-1495

10.2337/db06-1299

10.1177/112067211002000516

10.1046/j.1464-5491.2002.00820.x

10.2337/diacare.28.5.1163

10.1167/iovs.07-1633

10.1097/IIO.0b013e31819fd5d7

10.1155/2010/172593

10.2337/db09-0059

10.1016/j.diabres.2010.05.029

10.2337/db06-1373

10.2337/diabetes.47.5.821

10.1155/2010/861291

10.1016/j.ophtha.2010.07.020

10.1093/hmg/ddr121

10.1076/opge.24.1.41.13889

10.1016/j.diabres.2006.03.019

10.1016/S1056-8727(02)00187-3

10.1002/ajmg.10372

10.2337/dc06-1399

Suganthalakshmi B, 2006, Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy, Molecular vision, 12, 336

10.2337/db06-0021

10.1093/hmg/ddt161

Hammond C, 1996, Comparison between an ophthalmic optician and ophthalmologist in screening for diabetic retinopathy, Eye, 107

Buxton M, 1991, Screening for treatable diabetic retinopathy: a comparison of different methods, DiabetMed, 8, 371

Lienert R, 1989, Inter‐observer comparisons of ophthalmoscopic assessment of diabetic retinopathy, AustNZJOphthalmol, 17, 363

10.1046/j.1464-5491.2000.00250.x

10.1136/bjo.87.10.1258

10.5694/j.1326-5377.2005.tb00018.x

10.1016/j.ophtha.2011.04.009

International Council of Ophthalmology. Diabetic Eye Care. ICO Guidelines for Diabetic Eye Care.2014.http://www.icoph.org/taskforce‐documents/diabetic‐retinopathy‐guidelines.html.

GoldbergM FineS. Symposium on the Treatment of Diabetic Retinopathy Airlie House Warrenton Virginia.: Department of Health Education and Welfare.;1968.

10.2337/diab.34.3.S42

Kohner EPM, 1992, Screening for diabetic retinopathy: A field guide‐book

10.1016/S0161-6420(03)00475-5

National Institute for Clinical Excellence. Diabetic retinopathy – early management and screening.London UK2001.

10.1258/jms.2008.008015

10.1136/bmj.332.7532.3

10.1016/S0161-6420(01)00990-3

10.1016/S0002-9394(02)01522-2

10.1016/j.diabres.2013.05.006

10.2337/dc13-1292

10.1097/IAE.0b013e3182278b64

10.1046/j.1464-5491.2003.00969.x

10.1136/bjo.2005.072579

10.1258/135763306775321399

Sharma M, 2011, An integrated, mobile service for diabetic retinopathy in rural India, Community eye health / International Centre for Eye Health, 24, 17

10.1016/S0161-6420(00)00604-7

10.1682/JRRD.2005.08.0146

10.1016/j.ajo.2004.10.064

National Health Service (NHS). National Screening Programme for Diabetic Retinopathy.

2012, Diabetes care, 1

10.2165/00019053-200321080-00002

10.2337/diacare.17.8.909

10.1016/S0161-6420(91)32086-4

10.7326/0003-4819-124-1_Part_2-199601011-00017

10.1001/archopht.124.12.1754

10.1007/s00125-010-1836-3

Australia D, 2015, The Economic Impact of Diabetic Macular Oedema in Australia

10.1016/j.diabres.2008.03.011

10.2337/diacare.25.7.1159

10.2337/dc11-1635

10.1001/jamaophthalmol.2015.1312

10.1111/j.1442-9071.2011.02599.x

10.1136/bjo.2010.191312

10.2337/dc13-0816

10.1177/014572179802400406

10.1111/j.1464-5491.2006.01957.x

10.1001/archinte.166.17.1836

Serlachius AS, 2014, A randomized controlled trial of cognitive behaviour therapy to improve glycaemic control and psychosocial wellbeing in adolescents with type 1 diabetes, J Health Psychol

10.1136/pgmj.70.826.529

10.2337/db07-1605

10.1093/jn/131.10.2782S

The Diabetic Retinopathy Study Research Group, 1981, Ophthalmology, 583

10.1001/archopht.1985.01050110038020

10.1111/j.1464-5491.2003.01077.x

10.3310/hta19740

National Health Service England United Kingdom. Diabetic eye screening: commission and provide. 2015.

10.1111/j.1464-5491.2009.02870.x

10.1016/j.ophtha.2012.09.002

10.2337/diacare.15.10.1369

10.1056/NEJMoa1414264

10.1016/j.ophtha.2010.02.031

Xu H, 2005, P. Z. Present condition of ophthalmology resource in China in 2000, Medicine and Society, 18, 7

10.1007/s001250050867

10.1111/j.1442-9071.2011.02732.x

10.2337/diacare.16.6.889

Thông tin
Thông tin xuất bản

Clinical and Experimental Ophthalmology

Tập 44 Số 4

260-277

Thông tin tác giả